Showing results (441-450 of 454) with videos related to
Sort By:
Pageof 46
Angewandte Chemie (International Ed. in English)|August 4, 2020
A Photoaffinity-Based Fragment-Screening Platform for Efficient Identification of Protein LigandsEmma K Grant, David J Fallon, Michael M Hann, et al.Chemical Science|March 20, 2020
Manipulating molecules with strong coupling: harvesting triplet excitons in organic exciton microcavitiesDaniel Polak, Rahul Jayaprakash, Thomas P Lyons, et al.Leukemia & Lymphoma|September 21, 2020
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemiaMuhammad Umair Mushtaq, Alexandra M Harrington, Sibgha Gull Chaudhary, et al.Cell Metabolism|August 27, 2024
Serine and glycine physiology reversibly modulate retinal and peripheral nerve functionEsther W Lim, Regis J Fallon, Caleb Bates, et al.British Journal of Cancer|March 4, 2015
Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic reviewR D Neal, P Tharmanathan, B France, et al.Bone Marrow Transplantation|January 27, 2015
Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCTV Kosmoliaptsis, M M Jöris, D H Mallon, et al.Nature|January 25, 2023
Insulin-regulated serine and lipid metabolism drive peripheral neuropathyMichal K Handzlik, Jivani M Gengatharan, Katie E Frizzi, et al.Journal of Medicinal Chemistry|September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αPanayiotis A Procopiou, Niall A Anderson, John Barrett, et al.Journal of Medicinal Chemistry|September 1, 2010
Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroupPaul A Glossop, Charlotte A L Lane, David A Price, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 27, 2016
Extended interval dosing of natalizumab in multiple sclerosisL Zhovtis Ryerson, T C Frohman, J Foley, et al.Pageof 46